Clinical Trial Update: Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid Hemorrhage [NA]

View source ↗

Summary

A clinical trial evaluating esmolol (Brevibloc) to manage cardiac function in patients with subarachnoid hemorrhage was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Brevibloc (esmolol)

Snippet

Sponsor: University of Michigan | Conditions: Subarachnoid Hemorrhage | NA | Status: WITHDRAWN